ما هو فيروس الهانتا، المرض الذي أودى بحياة 3 ركاب في سفينة سياحية؟

Three people have died after a suspected outbreak of hantavirus on a cruise ship in the middle of the Atlantic ocean. At least one other passenger is in intensive care in South Africa.

The World Health Organization announced the deaths in a social media statement on Monday, along with one confirmed case of the rare disease. Authorities are investigating another five suspected cases among passengers travelling on the MV Hondius.

So, what is hantavirus? And why can it be so deadly?

As the investigation unfolds, here’s what we know.

What is hantavirus?

Hantavirus is a rare but severe respiratory illness that can cause severe bleeding, fever and even death.

The virus is spread by rodents, such as mice and rats, mainly through the urine and droppings of infected animals.

Hantavirus does not typically spread from person to person. However, in rare cases it may spread between people.

Globally, there are an estimated 150,000 to 200,000 cases of hantavirus each year.

It is less contagious than airborne viruses such as COVID and influenza, as it typically does not spread from person to person.

What makes it so deadly?

There are two main types of hantavirus, each with different symptoms.

Hantavirus pulmonary syndrome, which affects the lungs, is mainly found in the United States. If a person becomes infected with this type of hantavirus, within days they will likely experience coughing and shortness of breath.

As the illness progresses, they can develop symptoms such as fatigue, fever and muscle aches. They may also get headaches, dizziness, nausea, vomiting and abdominal pain. This is the most deadly kind of hantavirus. Tragically, about 38% of people who develop these symptoms die from the disease.

Hemorrhagic fever with renal syndrome is mainly found in Europe and Asia, but the strain known as the Seoul virus has spread around the world. This form of hantavirus mainly affects the kidneys.

People usually develop symptoms within two weeks of being exposed to this virus. Early symptoms include severe headaches, abdominal pain, nausea and blurred vision. More advanced symptoms include low blood pressure, internal bleeding and even acute kidney failure. This disease can be caused by different viruses and some are more deadly than others, meaning between 1% and 15% of cases can be fatal.

Unfortunately, there is no specific treatment or cure for either type of hantavirus. However, early medical treatment may increase a person’s chance of survival. This can include using respirators, oxygen therapy and dialysis.

Authorities are still investigating which type of hantavirus the passengers were exposed to.

How did it get on a cruise ship?

In a closed environment such as a cruise ship, there are two possible ways passengers could have contracted hantavirus.

One is being exposed to the virus while on a shore excursion.

The other possibility is that rodents may have entered the ship on cargo, and then spread the disease to passengers through their infected urine or droppings. Other factors such as hygiene standards and food storage practices may have caused the infection to spread more quickly.

To contain this suspected outbreak, authorities must first ensure any rodents are safely contained and removed from the ship. They should then monitor all passengers for hantavirus symptoms. The virus is diagnosed with a PCR test, similar to those used to diagnose viruses such as COVID.

Given there is no specific treatment for the disease, authorities must help any infected passengers manage their symptoms. This involves checking that they are breathing normally and their kidneys are functioning properly.

So, how worried should we be?

Although alarming, cases of hantavirus remain are extremely rare. But it can look similar to other respiratory illness, so you should always get symptoms checked. If you’ve been in regions where the virus is found and experience shortness of breath, fever or any other flu-like symptoms, see your GP.

Thomas Jeffries does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.